ARWR
BULLISH
$55.05
Live
Arrowhead Pharmaceuticals, Inc. · NASDAQ
Target $81.36
(+47.8%)
$9.57
52W Range
$76.76
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Confidence
85%
ARWR's Piotroski F-Score of 4/9 indicates weak financial health, with a notable debt/equity ratio of 1.24 and a lack of Altman Z-Score data, raising concerns about long-term solvency. However, the company exhibits exceptional profitability with a 75.5% ROE and 100% gross margin, supported by a staggering 10,461% YoY revenue growth. Despite a high current price of $55.05 and elevated valuation multiples (P/E: 34.41, P/S: 7.07), the stock trades at a premium due to explosive growth expectations. Analysts maintain a 'buy' consensus with a target price of $81.36, reflecting strong conviction in future upside. Insider selling activity, while bearish in sentiment, may reflect liquidity events rather than fundamental concerns.
Key Strengths
Exceptional 10,461% YoY revenue growth, indicating strong market traction
Outstanding 75.5% ROE and 18.54% profit margin, signaling high operational efficiency
100% gross margin suggests high-margin product portfolio or one-time revenue recognition
Strong analyst consensus with a 'buy' rating and $81.36 target price
Significant 1Y return of +265.3%, reflecting strong market momentum
Key Risks
Piotroski F-Score of 4/9 indicates weak financial health and potential instability
Debt/Equity ratio of 1.24 is elevated for a biotech firm, increasing financial leverage risk
No Altman Z-Score available; lack of bankruptcy risk assessment is a major red flag
Forward P/E of -12.81 indicates negative earnings expectations, raising sustainability concerns
Insider selling of $32.76M in last 6 months signals potential loss of confidence among leadership
AI Fair Value Estimate
Based on comprehensive analysis
$68.5
+24.4% above current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare ARWR against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning ARWR from our newsroom.
Newest → oldest
No matching news yet.